Russia will need about 1.5-2.5 years in order to create a vaccine against coronavirus and launch it into a series production, according to recent statements made by Dmitry Lioznov, an acting Director of the Smorodintsev Research Institute of Influenza, one of Russia’s leading research institutions in the field of influenza treatment. 24 March 2020
Chugai Pharmaceutical says that, along with majority-owner Roche and Genentech, has filed a patent infringement lawsuit in the US District Court for the District of Delaware as follows. 23 March 2020
US health technology assessor the Institute for Clinical and Economic Review (ICER) has now released a Draft Evidence Report assessing the comparative clinical effectiveness and value of obeticholic acid (Intercept Pharmaceuticals) for the treatment of non-alcoholic steatohepatitis (NASH). 20 March 2020
The European Medicines Agency issued a statement today saying it is aware of reports, especially on social media, which raise questions about whether non-steroidal anti-inflammatory medicines (NSAIDs) such as ibuprofen could worsen coronavirus disease (COVID-19). 18 March 2020
US Pharma major Bristol-Myers Squibb today announced that Elizabeth Mily has been appointed executive vice president, strategy and business development, effective March 30, 2020. 18 March 2020
Anglo-Swedish pharma major AstraZeneca today announced that Tom Keith-Roach has been appointed president of AstraZeneca UK, effective March 1. 12 March 2020
The US Food and Drug Administration (FDA) is postponing all but the most mission-critical inspections outside of the USA through April, in response to the COVID-19 outbreak. 10 March 2020
Following the publication of a 10 million ($11.14 million) call in January, the European Commission has secured an additional 37.5 million euros for urgently needed research on new coronavirus (COVID-19) vaccine development, treatment and diagnostics. 6 March 2020
As one of the largest healthcare services groups in Asia, Zuellig Pharma aims to strengthen its presence across Asia, saying it has acquired a controlling stake in Alliance Pharma (Cambodge), a leading healthcare distributor of Cambodia. 5 March 2020
German life sciences company Merck KGaA has formed a partnership to 3D print pharmaceutical tablets with Additive Manufacturing Customized Machines, part of EOS. 28 February 2020
The US regulator has granted Breakthrough Therapy designation for Debiopharm's novel chemo-radio sensitizer Debio 1143, for first-line head and neck cancer. 27 February 2020
Norbert Winkeljohann is to become chairman of Bayer’s supervisory board, replacing Werner Wenning, who will retire at the end of April 2020. 26 February 2020
Sweden-based infectious disease specialist Medivir has signed a licensing agreement for its Xerclear (acyclovir and hydrocortisone) for labial herpes with the Chinese company Shijiazhuang Yuanmai Biotechnology (SYB). 25 February 2020
The US Food and Drug Administration has approved the first adjuvanted quadrivalent influenza vaccine, Fluad Quadrivalent (influenza vaccine, adjuvanted), to help protect adults 65 years and older against seasonal influenza from Seqirus. 24 February 2020
Ireland-incorporated Endo International yesterday announced that Blaise Coleman, who has served as the company's executive vice president and chief financial officer since 2016, will succeed Paul Campanelli as president and chief executive and will become a member of the board of directors effective March 6, 2020. 20 February 2020
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has urged patients to report side effects when taking multiple medicines. 18 February 2020
UK-based Arctoris, which calls itself the developer of the world’s first fully automated drug discovery platform, has said that its new collaboration will tackle the industry’s ‘innovation crisis’. 17 February 2020
ViiV Healthcare, the specialist HIV company majority owned by GSK, today announced the presentation of new real-world evidence and implementation data showing the effectiveness, adherence, and quality-of-life improvement of Apretude (cabotegravir long-acting (CAB LA)) for HIV pre-exposure prophylaxis (PrEP). 16 October 2024
Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration (FDA)-approved mucoadhesive on the market indicated for the management of pain caused by oral mucositis 16 October 2024
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
US pharma major Eli Lilly has announced a strategic collaboration with two UK government departments and the devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. 16 October 2024
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Switzerland-based Novocure saw its shares rise 10% yesterday and leap a further 24% to $22.05 pre-market, after the company received a new US regulatory approval for its key product Optune Lua. 16 October 2024
Shares of Spanish drugmaker PharmaMar leapt more than 28% to 63.70 euros today, after it announced positive clinical trial findings for its combo lung cancer treatment, under development with USA-based Jazz Pharmaceuticals, which rose 4.2%. 15 October 2024
Novartis has discontinued an early Phase II trial of LTP001 in idiopathic pulmonary fibrosis (IPF). The company confirmed that the decision was not related to safety, with no issues emerging in the study. 15 October 2024
US pharma major Eli Lilly has announced plans to invest around 1.5 billion renminbi ($206 million) into expanding its manufacturing facility in Suzhou, China. 15 October 2024
Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. 15 October 2024
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
India's Central Drugs Standard Control Organization (CDSCO) has provided a favorable recommendation for its novel antibiotic Miqnaf (nafithromycin) discovered and developed for the treatment of community-acquired bacterial pneumonia (CABP) in adults. 14 October 2024
The Danish Medicines Council (Medicinrådet), responsible for evaluating and recommending new treatments for Denmark’s healthcare system, is facing a significant increase in processing times. 14 October 2024
The South African Health Products Regulatory Authority (SAHPRA) and the Australian Therapeutic Goods Administration (TGA) have signed a Memorandum of Understanding (MoU), which will strengthen collaboration between the two health product regulators. 14 October 2024
California-based AI company Suki has raised $70 million in new funding to accelerate the growth of its AI-powered voice solutions in healthcare. 11 October 2024
Pfizer is to present initial findings from its CULTIVATE study of its sphingosine-1-phosphate (S1P) receptor modulator Velsipity (etrasimod) in Crohn’s disease (CD) at United European Gastroenterology Week 2024. 11 October 2024
Switzerland-based KeyBioscience and US pharma major Eli Lilly have agreed to extend their collaboration on the development of dual amylin calcitonin receptor agonists (DACRA), a new class of potential treatments for obesity and related disorders. 11 October 2024